Our research has shown that, in SLE patients, elevated serum IL-6 levels (>1.53 pg/mL) are associated with an increased risk of constitutional symptoms (fever), lung disease, and cardiovascular changes. Here, IL6 is linked to systemic lupus erythematosus.